BE853810A - Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu - Google Patents

Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu

Info

Publication number
BE853810A
BE853810A BE176892A BE176892A BE853810A BE 853810 A BE853810 A BE 853810A BE 176892 A BE176892 A BE 176892A BE 176892 A BE176892 A BE 176892A BE 853810 A BE853810 A BE 853810A
Authority
BE
Belgium
Prior art keywords
vaccine
virus
preparing
procedure
equine rhinopneumonia
Prior art date
Application number
BE176892A
Other languages
English (en)
Original Assignee
Philips Roxane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Roxane filed Critical Philips Roxane
Publication of BE853810A publication Critical patent/BE853810A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE176892A 1976-04-23 1977-04-21 Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu BE853810A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/679,840 US4110433A (en) 1976-04-23 1976-04-23 Equine rhinopneumonitis virus

Publications (1)

Publication Number Publication Date
BE853810A true BE853810A (fr) 1977-10-21

Family

ID=24728588

Family Applications (1)

Application Number Title Priority Date Filing Date
BE176892A BE853810A (fr) 1976-04-23 1977-04-21 Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu

Country Status (14)

Country Link
US (1) US4110433A (fr)
AU (1) AU2454077A (fr)
BE (1) BE853810A (fr)
DD (1) DD131762A5 (fr)
DE (1) DE2717919A1 (fr)
ES (1) ES458113A1 (fr)
FR (1) FR2348704A1 (fr)
GB (1) GB1570732A (fr)
LU (1) LU77166A1 (fr)
NL (1) NL7704239A (fr)
NZ (1) NZ183907A (fr)
PL (1) PL197579A1 (fr)
SE (1) SE7704514L (fr)
SU (1) SU700069A3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
WO1992002252A1 (fr) * 1990-08-01 1992-02-20 Research Corporation Technologies, Inc. Gene codant pour la glycoproteine d de l'herpesvirus de type 1, son produit genetique, anticorps et leurs emplois
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
CA2243730C (fr) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Vaccin contre streptococcus equi
MXPA02002566A (es) * 1999-09-10 2002-10-23 Akzo Nobel Nv Mutante del virus de herpes equino sensible a la temperatura y vacuna viva del mismo.
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
EP3167900B1 (fr) 2006-03-29 2018-11-21 Merial Limited Vaccin contre des streptocoques
CN114214289A (zh) * 2021-12-24 2022-03-22 山东省农业科学院畜牧兽医研究所 一株马冠状病毒ECoV464693及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1692043C3 (de) * 1968-03-06 1979-04-12 Behringwerke Ag, 3550 Marburg Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
ES458113A1 (es) 1978-03-16
NZ183907A (en) 1979-10-25
DD131762A5 (de) 1978-07-19
FR2348704A1 (fr) 1977-11-18
SE7704514L (sv) 1977-10-24
SU700069A3 (ru) 1979-11-25
US4110433A (en) 1978-08-29
DE2717919A1 (de) 1977-11-03
GB1570732A (en) 1980-07-09
NL7704239A (nl) 1977-10-25
LU77166A1 (fr) 1977-08-12
AU2454077A (en) 1978-10-26
PL197579A1 (pl) 1978-09-25

Similar Documents

Publication Publication Date Title
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
IT7820811A0 (it) Fenossi-benzil-ossicarbonil-derivati sostituiti, procedimento per laloro preparazione e loro impiegocome insetticidi e come acaricidi.
ES516286A0 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
FR2348704A1 (fr) Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
IT7820264A0 (it) Oligopeptidi trifluorometilati, procedimento per la loro preparazione e loro applicazione terapeutica.
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
IT8023392A0 (it) N-propionilsarcosinanilidi, procedimento per la loro preparazione e prodotti medicinali a base di queste sostanze.
IT1207271B (it) Amminoglicosidi, procedimento per la loro preparazione e loro impiego.
NL174345C (nl) Zuur alkalicitraat, werkwijze ter bereiding daarvan en therapeutisch preparaat.
IT7926898A0 (it) Procedimento per preparare 1,2,3-tiadiazol-5-il-uree.
ES523243A0 (es) "procedimiento para preparar derivados de 1,4-dihidropiridina".
AR225920A1 (es) Aldehido-eteres alifaticos,procedimiento para su preparacion y procedimiento para producir butirolactona,butano-1-diol y tetrahidrofurano a partir de los mismos
RO71162A (fr) Procede pour la preparation des 7-(alpha-(2,3-dihidro-2-oxo-1h-benzimidazole-1-ilcarbonyle-amino)-ary-acetamido)-cephalosporines
IL57230A0 (en) Substituted alkanyl-azolyl oxime-carbamates,their preparation and their use as insecticides,acaricides and nematocides
IT8320023A0 (it) Carbacicline, procedimento per laloro preparazione e loro impiegocome medicinali.
LU79503A1 (fr) Procede de preparation d'un vaccin syncytial du virus respiratoire
RO75739A (fr) Procede pour la preparation des carbamoyle-triazolile-o,n-acetals
IL52586A0 (en) O-ethyl-s-kappa-propyl-0-2,2,2-trihaloethylphosphoro-thiolates and -thionothiolates, their preparation and their use as insecticides,acaricides and nematocides
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
IT7829638A0 (it) 2,4-diammino-5-benzil-pirimidine eprocedimento per la loro preparazione.
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.
MX6219E (es) Procedimiento para preparar derivados de 1,1'-bifenil-2-il-alquilamina
IT1099797B (it) 1. 4-idro-firidazine 1-n-sostituite, procedimento per la loro preparazione e loro impiego come prodoiti medicinali